Predicting survival of patients with spinal metastatic disease using PathFx 3.0 – A validation study of 668 patients in Sweden

INTRODUCTION: PathFx is a computer-based prediction model for estimating survival of patients with bone metastasis. The model has been validated in several studies, but this is the first validation using exclusively patients with spinal metastases. RESEARCH QUESTION: Is PathFx 3.0 a tool useful for...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrwik, Christian, Tsagkozis, Panagiotis, Wedin, Rikard, Robinson, Yohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729818/
https://www.ncbi.nlm.nih.gov/pubmed/36506283
http://dx.doi.org/10.1016/j.bas.2022.101669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729818/
https://www.ncbi.nlm.nih.gov/pubmed/36506283
http://dx.doi.org/10.1016/j.bas.2022.101669

Ejemplares similares